Stock Events

Cara Therapeutics (CARA) Q3 2024 Earnings

14AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.59
-0.48
-0.38
-0.27

Details

Expected EPS
-0.274
Actual EPS
-0.27
Surprise EPS
0
Surprise Percent
+1.46%

Description

Cara Therapeutics (CARA) has reported earnings of -0.27 per share for Q3 2024.

0 Comments

Share your thoughts